姓名：王拥军 性别：男 职称：主任医师、教授 招生院所：附属天坛医院 招生类型：科学与专业学位(博) 科学与专业学位(硕) 招生专业：神经病学(博) 神经病学(硕) 研究方向名称：脑血管病 电子信箱：yongjunwang@ncrcnd.org.cn


社会任职
1. 世界卒中组织理事
2. 中华预防医学会卒中预防与控制专业委员会主任委员
3. 全国继续医学教育委员会专家委员
4. 美国心脏病学会卒中专家委员会/美国卒中学会/美国心脏病学会生理与代谢分会委员
5. 中国医师协会循证医学专业委员会第二届委员会常务委员
6. 中华医学会神经病学分会 主任委员
7. 《CNS Neuroscience & Therapeutics》副主编
8. 中国卒中学会 常务副会长
9. 《SVN》杂志主编
10. 清华大学医学院未来医学影像实验室 临床医学顾问
11. 中国医院协会医疗质量管理专委会 副主任委员
12. 国家基本公共卫生服务项目基层高血压管理专家委员会 第一届副主任委员
13. 中华预防医学会 常务委员
14. 首都医科大学人脑保护高精尖创新中心学术委员会 副主任委员
15. 首届全国科技领军人才联盟常务理事
16. 国家卫生计生委能力建设与继续教育中心学科建设与科研管理分会委员会委员
17. 中国医师协会医学机器人医师分会 第一届委员会委员
18. 《中华神经科杂志》编辑委员
19. 中国医师协会毕业后医学教育专家委员会 委员
20. 中国医师协会毕业后医学教育神经内科专业委员会 主任委员
21. 健康中国行动推进委员会专家咨询委员会 委员
22. 中国卫生经济学会卫生技术评估专业委员会 副主任委员
23. 首届中国生物医药整合联盟 副理事长
24. 叙事医学杂志 第一届编委会委员
25. 中国医院协会 理事
26. 首届全国科技领军人才联盟生物与医药专业委员会 副主任
27. 中国医师协会神经内科医师分会 副会长
个人简历
1. 197810-198210:河北医学院 本科
2. 198210-198609:河北唐山市工人医院 神经内科医师
3. 198609-198908:首都医科大学 神经病学硕士研究生
4. 198908-199109:首都医科大学宣武医院 神经内科医师
5. 199109-199412:首都医科大学宣武医院 神经内科主治医师
6. 199412-199603:首都医科大学宣武医院 神经内科副主任医师
7. 199603-200009:首都医科大学宣武医院 神经内科副主任
8. 199902-200008:美国阿肯色医科大学 博士后
9. 200009-200203:首都医科大学附属北京天坛医院 神经内科主任
10. 200203-200303:首都医科大学附属北京天坛医院 院长助理、神经内科主任
11. 200303-201704:首都医科大学附属北京天坛医院 副院长
12. 200309-200407:北京大学 EMBA
13. 200507-200606:中欧管理学院 EMBA
14. 201704-:首都医科大学附属北京天坛医院 常务副院长、党委副书记
重要学术论文
1. Mo, J.# Chen, Z.# Xu, J.# Wang, A. Dai, L. Cheng, A. Meng, X. Li, H. Wang, Y.*.Efficacy of Clopidogrel-Aspirin Therapy for Stroke Does Not Exist in CYP2C19 Loss-of-Function Allele Noncarriers With Overweight/Obesity. Stroke. 2020,51 (1):224-231.SCI
2. Wang, A.# Dai, L.# Zhang, N. Lin, J. Chen, G. Zuo, Y. Li, H. Wang, Y. Meng, X.* Wang, Y.*.Oxidized low-density lipoprotein (LDL) and LDL cholesterol are associated with outcomes of minor stroke and TIA. Atherosclerosis. 2020,297:74-80.SCI
3. Wang, A.# Li, H.# Yuan, J. Zuo, Y. Zhang, Y. Chen, S. Wu, S. Wang, Y.*.Visit-to-Visit Variability of Lipids Measurements and the Risk of Stroke and Stroke Types: A Prospective Cohort Study. J Stroke. 2020,22 (1):119-129.SCI
4. Pan, Y.* Zhang, L. Li, Z. Meng, X. Wang, Y. Li, H. Liu, L. Wang, Y.*.Cost-Effectiveness of a Multifaceted Quality Improvement Intervention for Acute Ischemic Stroke in China. Stroke. 2020,51 (4):1265-1271.SCI
5. Li, J. Wang, Y. Li, H. Zuo, Z. Lin, J. Wang, A. Zhao, X. Liu, L. Wang, Y.*.Homocysteine Level Predicts Response to Dual Antiplatelet in Women With Minor Stroke or Transient Ischemic Attack: Subanalysis of the CHANCE Trial. Arterioscler Thromb Vasc Biol. 2020,40 (3):839-846.SCI
6. Lu, L.# Xiong, W.# Yang, X. Ma, X. Wang, C. Yan, B. Zhang, Q. Mu, J. Zhang, Y. Gao, H. Liu, W. Zhang, L. Li, Z. Sander, J. W. Wang, Y.* Zhou, D.*.In-hospital mortality of status epilepticus in China: Results from a nationwide survey. Seizure. 2020,75:96-100.SCI
7. Yang, M.# Wang, A.# Li, J. Zhao, X. Liu, L. Meng, X. Jing, J. Zhang, N. Johnston, S. C. Wang, Y.* Wang, Y.*.Lp-PLA(2) and dual antiplatelet agents in intracranial arterial stenosis. Neurology. 2020,94 (2):e181-e189.SCI
8. Du, W. Zhao, X. Wang, Y. Zhang, G. Fang, J. Pan, Y. Liu, L. Dong, K. Liu, G. Wang, Y.*.The PLAN score can predict poor outcomes of intracerebral hemorrhage. Ann Transl Med. 2020,8 (1):14.SCI
9. Rao, Z. Z. Gu, H. Q. Wang, X. W. Xie, X. W. Yang, X. Wang, C. J. Zhao, X. Xian, Y. Wang, Y. L. Li, Z. X.* Xiao, R. P. Wang, Y. J.*.Renal Dysfunction and In-Hospital Outcomes in Patients With Acute Ischemic Stroke After Intravenous Thrombolytic Therapy. J Am Heart Assoc. 2019,8 (20):e012052.SCI
10. Tang, H. Mo, J. Chen, Z. Xu, J. Wang, A. Dai, L. Cheng, A. Wang, Y.*.Uric Acid Contributes to Obesity-Paradox of the Outcome of Ischemic Stroke. Front Neurol. 2019,10:1279.SCI
11. Chen, Z.# Mo, J.# Xu, J. Qin, H. Zheng, H. Pan, Y. Meng, X. Jing, J. Xiang, X. Wang, Y.*.Risk Profile of Ischemic Stroke Caused by Small-Artery Occlusion vs. Deep Intracerebral Hemorrhage. Front Neurol. 2019,10:1213.SCI
12. Wang, Y.#* Chen, W.# Lin, Y. Meng, X. Chen, G. Wang, Z. Wu, J. Wang, D. Li, J. Cao, Y. Xu, Y. Zhang, G. Li, X. Pan, Y. Li, H. Zhao, X. Liu, L. Lin, J. Dong, K. Jing, J. Johnston, S. C. Wang, D. Wang, Y.*.Ticagrelor plus aspirin versus clopidogrel plus aspirin for platelet reactivity in patients with minor stroke or transient ischaemic attack: open label, blinded endpoint, randomised controlled phase II trial. BMJ. 2019,365:l2211.SCI
13. Li, Z.# Jiang, Y.# Li, H. Xian, Y. Wang, Y.*.China's response to the rising stroke burden. BMJ. 2019,364:l879.SCI
14. Zhang, C. Wang, Y. Zhao, X. Liu, L. Wang, C. Li, Z. Pu, Y. Zou, X. Pan, Y. Wang, Y.*.Clinical, imaging features and outcome in internal carotid artery versus middle cerebral artery disease. PLoS One. 2019,14 (12):e**.SCI
15. Zhang, X.# Li, S. Y.# Jing, J. Pan, Y. S. Yan, H. Y. Meng, X. Zhao, X. Q. Liu, L. P. Wang, C. X. Wang, Y. L. Wang, Y. J.*.Inpatient statin use and stroke recurrence in patients with or without diabetes mellitus. Neurol Res. 2019,41 (10):893-899.SCI
16. Quan, K. Wang, A. Zhang, X. Wang, Y.*.Leukocyte Count and Adverse Clinical Outcomes in Acute Ischemic Stroke Patients. Front Neurol. 2019,10:1240.SCI
17. Chen, G. Wang, A. Li, S. Zhao, X. Wang, Y. Li, H. Meng, X. Knibbs, L. D. Bell, M. L. Abramson, M. J. Wang, Y.* Guo, Y.*.Long-Term Exposure to Air Pollution and Survival After Ischemic Stroke. Stroke. 2019,50 (3):563-570.SCI
18. Xu, J. Wang, A. Meng, X. Jing, J. Wang, Y. Wang, Y.*.Obesity-Stroke Paradox Exists in Insulin-Resistant Patients But Not Insulin Sensitive Patients. Stroke. 2019,【未填写卷（期）】:Strokeaha.SCI
19. Ma, Y. Liu, Y. Xu, J. Wang, Y. Du, F.* Wang, Y.*.The influence of mean arterial pressure on the efficacy and safety of dual antiplatelet therapy in minor stroke or transient ischemic attack patients. J Clin Hypertens (Greenwich). 2019,21 (5):598-604.SCI
20. Pan, Y. Elm, J. J. Li, H. Easton, J. D. Wang, Y. Farrant, M. Meng, X. Kim, A. S. Zhao, X. Meurer, W. J. Liu, L. Dietrich, D. Wang, Y.* Johnston, S. C.*.Outcomes Associated With Clopidogrel-Aspirin Use in Minor Stroke or Transient Ischemic Attack: A Pooled Analysis of Clopidogrel in High-Risk Patients With Acute Non-Disabling Cerebrovascular Events (CHANCE) and Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trials. JAMA Neurol. 2019,76 (12):1466-1473.SCI
21. Yang, M. Pan, Y. Li, Z. Yan, H. Zhao, X. Liu, L. Jing, J. Meng, X. Wang, Y.* Wang, Y.*.Platelet Count Predicts Adverse Clinical Outcomes After Ischemic Stroke or TIA: Subgroup Analysis of CNSR II. Front Neurol. 2019,10:370.SCI
22. Chen, W. Pan, Y. Jing, J. Zhao, X. Liu, L. Meng, X. Wang, Y. Lin, Y.* Wang, Y.*.Association of Body Mass Index and Risk of Stroke After Acute Minor Stroke or TIA: a Post Hoc Analysis of a Randomized Controlled Trial. Neurotox Res. 2019,36 (4):836-843.SCI
23. Pan, Y.* Li, H. Wang, Y. Meng, X. Wang, Y.*.Causal Effect of Lp(a) [Lipoprotein(a)] Level on Ischemic Stroke and Alzheimer Disease: A Mendelian Randomization Study. Stroke. 2019,50 (12):3532-3539.SCI
24. Li, S. Y. Yang, X. M. Zhao, X. Q. Liu, L. P. Wang, Y. L. Jiang, Y. Wang, Y. J.*.Newly detected atrial fibrillation is associated with cortex-involved ischemic stroke. Chin Med J (Engl). 2019,132 (17):2053-2058.SCI
25. Pan, Y. Chen, W. Wang, Y.*.Prediabetes and Outcome of Ischemic Stroke or Transient Ischemic Attack: A Systematic Review and Meta-analysis. J Stroke Cerebrovasc Dis. 2019,28 (3):683-692.SCI
26. Yang, M. Huo, X. Gao, F. Wang, A. Ma, N. Liebeskind, D. S. Wang, Y.* Miao, Z.*.Safety and Efficacy of Heparinization During Mechanical Thrombectomy in Acute Ischemic Stroke. Front Neurol. 2019,10:299.SCI
27. Wang, Y.* Johnston, S. C. Bath, P. M. Grotta, J. C. Pan, Y. Amarenco, P. Wang, Y. Simon, T. Kim, J. S. Jeng, J. S. Liu, L. Lin, Y. Wong, K. S. L. Wang, D. Li, H..Acute dual antiplatelet therapy for minor ischaemic stroke or transient ischaemic attack. BMJ. 2019,364:l895.SCI
28. Xu, J.# Dai, L.# Chen, Z.# Wang, A. Mo, J. Cheng, A. Meng, X. Wang, Y. Zhao, X. Wang, Y.*.Acute-phase blood pressure trajectories and clinical outcomes in ischemic stroke. J Clin Hypertens (Greenwich). 2019,21 (8):1108-1114.SCI
29. Xie, X.# Gu, H. Q.# Wang, X. Chen, P. Liu, L. Li, Z. Meng, X. Wang, Y. Wang, Y.*.Assessing the applicability of 2017 ACC/AHA hypertension guidelines for secondary stroke prevention in the BOSS study. J Clin Hypertens (Greenwich). 2019,21 (10):1534-1541.SCI
30. Pan, Y. Chen, W. Wang, Y. Li, H. Johnston, S. C. Simon, T. Zhao, X. Liu, L. Wang, D. Meng, X. Wang, Y.*.Association Between ABCB1 Polymorphisms and Outcomes of Clopidogrel Treatment in Patients With Minor Stroke or Transient Ischemic Attack: Secondary Analysis of a Randomized Clinical Trial. JAMA Neurol. 2019,76 (5):552-560.SCI
31. Yang, X. M.# Rao, Z. Z.# Gu, H. Q.# Zhao, X. Q. Wang, C. J. Liu, L. P. Liu, C. Wang, Y. L. Li, Z. X.* Xiao, R. P. Wang, Y. J.*.Atrial Fibrillation Known Before or Detected After Stroke Share Similar Risk of Ischemic Stroke Recurrence and Death. Stroke. 2019,50 (5):1124-1129.SCI
32. Xu, J.# Liu, Y.# Wang, A. Gao, Y. Wang, Y. Wang, Y.*.Blood pressure fluctuation pattern and stroke outcomes in acute ischemic stroke. Hypertens Res. 2019,42 (11):1776-1782.SCI
33. Chen, Z. Qin, H. Liu, J. Wu, B. Cheng, Z. Jiang, Y. Liu, L. Jing, L. Leng, X. Jing, J. Wang, Y. Wang, Y.*.Characteristics of Wall Shear Stress and Pressure of Intracranial Atherosclerosis Analyzed by a Computational Fluid Dynamics Model: A Pilot Study. Front Neurol. 2019,10:1372.SCI
34. Xu, J.# Wang, A.# Wangqin, R.# Mo, J. Chen, Z. Dai, L. Meng, X. Zhao, X. Wang, Y. Li, H. Chen, W. Xian, Y. Wang, Y.*.Efficacy of clopidogrel for stroke depends on CYP2C19 genotype and risk profile. Ann Neurol. 2019,86 (3):419-426.SCI
35. Ming Yang，Xiaochuan Huo，Zhongrong Miao，Yongjun Wang*.Platelet Glycoprotein IIb/IIIa Receptor Inhibitor Tirofiban in Acute Ischemic Stroke. Drugs. 2019,1(6):1-15.SCI
36. Na We，Yiming Deng，Li Yao，Weili Jia，Jinfang Wang，Qingli Shi，Hongyan Chen，Yuesong Pan，Hongyi Yan，Yumei Zhang，*Yongjun Wang*.A Neuroimaging Marker Based on Diffusion Tensor Imaging and Cognitive Impairment Due to Cerebral White Matter Lesions. Frontiers in Neurology. 2019,10:1-7.SCI
37. Yuesong Pan，Weiqi Chen，Yongjun Wang*.Prediabetes and Outcome of Ischemic Stroke or Transient Ischemic Attack: A Systematic Review and Meta-analysis. Journal of Stroke and Cerebrovascular Diseases. 2018,28(3):1-10.SCI
38. Liping Liu，#Jingyi Liu，#Yilong Wang，David Wang，Yongjun Wang*.Substantial Improvement of Stroke Care in China. Stroke. 2018,49:3085-3091.SCI
39. Chunjuan Wang，#Yingying Yang，#Yuesong Pan，Xiaoling Liao，Xiaochuan Huo，Zhongrong Miao，Yongjun Wang，*Yilong Wang*.Validation of the Simplified Stroke-Thrombolytic Predictive Instrument to Predict Functional Outcomes in Chinese Patients. Stroke. 2018,49:1-4.SCI
40. Shichao Sun，#Yuesong Pan，#Lei Bai，Xingquan Zhao，Liping Liu，Hao Li，Yilong Wang，Li Guo，*Yongjun Wang*.GWTG Risk Model for All Stroke Types Predicts In-Hospital and 3-Month Mortality in Chinese Patients with Acute Stroke. Journal of Stroke and Cerebrovascular Diseases. 2018,28(3):1-7.SCI
41. Anxin Wang，#Shiyu Li，#Nan Zhang，Liye Dai，Yingting Zuo，Yilong Wang，Xia Meng，Yongjun Wang*.Oxidized Low-Density Lipoprotein to High-Density Lipoprotein Ratio Predicts Recurrent Stroke in Minor Stroke or Transient Ischemic Attack. Stroke. 2018,49:2637-2642.SCI
42. Jiaqing Wang，#Xia Chen，#Baoshi Yuan，Weicong Wang，Chunmin Xu，Weiwei Zhao，Pengpeng Zhao，Yilong Wang，Xingquan Zhao，Yongjun Wang.Bioavailability of Edaravone Sublingual Tablet Versus Intravenous Infusion in Healthy Male Volunteers. Clinical Therapeutics. 2018,40(10):1-9.SCI
43. Zhou, Y. Zhang, Y. Pan, Y. Jing, J. Zhao, X. Liu, L. Wang, C. Li, H. Yan, H. Meng, X. Wang, Y.* Wang, Y.*.Insulin Resistance Index from Oral Glucose Tolerance Test Predicts Ischemic Stroke Outcomes in Non-Diabetic Patients with Different Estimated Glomerular Filtration Rate Strata. Cerebrovascular Diseases. 2018,46:140-149.SCI
44. Wang, Y. Li, Z. Zhao, X. Wang, C. Wang, X. Wang, D. Liang, L. Liu, L. Wang, C. Li, H. Shen, H. Bettger, J. Pan, Y. Jiang, Y. Yang, X. Zhang, C. Han, X. Meng, X. Yang, X. Kang, H. Yuan, W. Fonarow, G. C. Peterson, E. D. Schwamm, L. H. Xian, Y. Wang, Y.* Golden Bridge-Ais Investigators.Effect of a Multifaceted Quality Improvement Intervention on Hospital Personnel Adherence to Performance Measures in Patients With Acute Ischemic Stroke in China A Randomized Clinical Trial. JAMA. 2018,320(3):245-254.SCI
45. Xinmiao Zhang，Jing Jing，Xingquan Zhao，Liping Liu，Chunxue Wang，Yuesong Pan，Xia Meng，Yilong Wang，*Yongjun Wang*.Statin Use during Hospitalization and Short-Term Mortality in Acute Ischaemic Stroke with Chronic Kidney Disease. European Journal of Neurology. 2018,79:296–302.SCI
46. Lixia Zong，#Xianwei Wang，#Zixiao Li，Xingquan Zhao，Liping Liu，Hao Li，Xia Meng，Yilong Wang，*Yongjun Wang*.Alkaline Phosphatase and Outcomes in Patients With Preserved Renal Function Results From China National Stroke Registry. Stroke. 2018,49:1-7.SCI
47. Zhang X, Jing J, Zheng H, Jia Q, Zhao X, Liu L, Wang C, Meng X, Pan Y, Wang Y, Wang Y*; Investigators for ACROSS-China..Prognosis of Intracerebral Hemorrhage with Newly Diagnosed Diabetes Mellitus According to Hemoglobin A1c Criteria. Journal of Stroke Cerebrovascular Diseases. 2018,27(5):1127–1133.SCI
48. Xinmiao Zhang，Jing Jing，Xingquan Zhao，Liping Liu，Xia Meng，Anxin Wang，Yuesong Pan，David Wang，Yilong Wang，*Yongjun Wang*.Prognosis of dolichoectasia in non-cardioembolic transient ischemic attack and minor stroke. Neurological Research. 2018,40(6):1-7.SCI
49. Xinmiao Zhang，#Jing Jin，#Kehui Dong，Yilong Wang，*Yongjun Wang*.Teaching NeuroImages: Vertebrobasilar dolichoectasia with dissection manifested as infarct and subarachnoid hemorrhage. Neurology. 2018,90:e990-e991.SCI
50. Yu Wu，#Yilun Zhou，#Yuesong Pan，#Xingquan Zhao，Liping Liu，David Wang，Chunxue Wang，Hao Li，S. Claiborne Johnston，Xia Meng，Yilong Wang，*Yongjun Wang，*on behalf of the CHANCE Investigators.Impact of CYP2C19 polymorphism in prognosis of minor stroke or TIA patients with declined eGFR on dual antiplatelet therapy: CHANCE substudy. The Pharmacogenomics Journal. 2018,18(6):1-8.SCI
51. Liye Dai，#Lu Song，#Xiaoli Li，#Yuling Yang，Xiaoming，Yuntao Wu，Chunhui Li，Hualing Zha，Yilong Wang，Shouling Wu，Yongjun Wang*.Association of visit-to-visit blood pressure variability with the risk of all-cause mortality and cardiovascular events in general population. J Clin Hypertens. 2018,20(2):1-9.SCI
52. Bihong Zhu，#Yuesong Pan，#Jing Jing，Xia Meng，Xingquan Zhao，Liping Liu，David Wang，Claiborne Johnston，Hao Li，Yilong Wang*，Zhimin Wang*，Yongjun Wang*，On behalf of the CHANCE Investigators.Neutrophil counts, neutrophil ratio, and new stroke in minor ischemic stroke or TIA. Neurology. 2018,90(21):e1870-e1878.SCI
53. Wang Y#*, Li Z, Wang Y, Zhao X, Liu L, Yang X, Wang C, Gu H, Zhang F, Wang C, Xian Y, Wang DZ, Dong Q, Xu A, Zhao J..Chinese Stroke Center Alliance: a national effort to improve healthcare quality for acute stroke and transient ischaemic attack: rationale, design and preliminary findings. Stroke and Vascular Neurology. 2018,3(4):1-7.
54. Xinmiao Zhang，#Zixiao Li，#Xingquan Zhao，Ying Xian，Liping Liu，Chunxue Wang，Chunjuan Wang，Hao Li，Janet Prvu Bettger，Qing Yang，David Wang，Yong Jiang，Xiaolei Bao，Xiaomeng Yang，Yilong Wang，*Yongjun Wang*.Relationship between hospital performance measures and outcomes in patients with acute ischaemic stroke: a prospective cohort study. BMJ Open. 2018,8:1-9.SCI
55. Xinmiao Zhang，Qiuyan Shi，Huaguang Zheng，Qian Jia，Xingquan Zhao，Liping Li，Chunxue Wang，Xia Meng，Jing Jing，Yuesong Pan，Yilong Wang，*Yongjun Wang*.Prevalence of Abnormal Glucose Regulation according to Different Diagnostic Criteria in. BioMed Research International. 2018,2018:**:1-8.SCI
56. Bihong Zhu，#Huihui Liu，#Yuesong Pan，#Jing Jing，Hao Li，Xingquan Zhao，Liping Liu，David Wang，S. Claiborne Johnston，Zhimin Wang，Yilong Wang*，Yongjun Wan*，on behalf of the CHANCE Investigators.Elevated Neutrophil and Presence of Intracranial Artery Stenosis Increase the Risk of Recurrent Stroke. Stroke. 2018,49:2294-2300.SCI
57. Yilong Wang，#Zixiao Li，#Xingquan Zhao，Liping Liu，Chunxue Wang，Chunjuan Wang，Eric D. Peterson，Lee H. Schwamm，Gregg C. Fonarow，Sidney C. Smith，Janet Bettger，David Wang，Hao Li，Ying Xian，Yongjun Wang*.Evidence-Based Performance Measures and Outcomes in Patients With Acute Ischemic Stroke Findings From the China National Stroke Registry. Circulation: Cardiovascular Quality and Outcomes. 2018,11:1-10.SCI
58. Li J, Wang A, Zhao X, Liu L, Meng X, Lin J, Jing J, Zou X, Wang Y*, Wang Y* and Investigators C.High-sensitive C-reactive protein and dual antiplatelet in intracranial arterial stenosis. Neurology. 2018,90(6):e447-e454.SCI
59. Liu Q#, Wang X#, Wang Y, Wang C, Zhao X, Liu L, Li Z, Meng X, Guo L* and Wang Y*.Association between marriage and outcomes in patients with acute ischemic stroke. Journal of neurology. 2018,265(4):942-948.SCI
60. Wang Y and Wang Y#.Stroke research in 2017: surgical progress and stem-cell advances. Lancet Neurol. 2018,17(1):2-3.SCI
61. Liu R, Yang X, Li S, Jiang Y, Wang Y and Wang Y.Modified CHADS2 and CHA2DS2-VASc scores to predict atrial fibrillation in acute ischemic stroke patients. J Clin Neurosci. 2018,51:35-38.SCI
62. Zixiao Li，#Xianwei Wang，#Huiman Xie Barnhart，Yongjun Wang*.Working With Statisticians in Clinical Research. Stroke. 2018,49:e311-e313.SCI
63. Suo Y#, Chen W#, Pan Y, Peng Y, Yan H, Li W, Liu G*, Wang Y*..Magnetic Resonance Imaging Markers of Cerebral Small Vessel Disease in Hematoma Expansion of Intracerebral Hemorrhage.. J Stroke Cerebrovasc Dis. . 2018,27(7):2006-2013.SCI
64. Suo Y#, Chen WQ#, Pan YS, Peng YJ, Yan HY, Zhao XQ, Liu LP, Wang YL, Liu GF*, Wang YJ*..The max-intracerebral hemorrhage score predicts long-term outcome of intracerebral hemorrhage.. CNS Neurosci Ther. . 2018,24(12):1149-1155.SCI
65. Ping Sun，#Liping Liu，#Yuesong Pan，Xianwei Wang，Donghua Mi，Yuehua Pu，Xin Liu，Wanying Duan，Hongyi Yan，Chunxue Wang，Xingquan Zhao，Yilong Wang，Yongjun Wang*,on behalf of CICAS investigators.Intracranial Atherosclerosis Burden and Stroke Recurrence for Symptomatic Intracranial Artery Stenosis (sICAS). Aging and Disease. 2018,9(6):1096-1102.SCI
66. Yan Ma，Ying Liu，Jie Xu，Yilong Wang，Yongjun Wang*，Fenghe Du*.Effect of dual antiplatelet on recurrent stroke in minor stroke or TIA depends on bodyweight. Therapeutics and Clinical Risk Management. 2018,14:861-870.SCI
67. Yi Lin，Zixiao Li，Chelsea Liu，Yongjun Wang*.Towards precision medicine in ischemic stroke and transient ischemic attack. Frontiers In Bioscience. 2018,23:1338-1359.SCI
68. Liping Liu#，Jing Ding#，Xinyi Leng#，Yuehua Pu，Li-An Huang，Anding Xu，Ka Sing Lawrence Wong，Xin Wang*，Yongjun Wang*.Guidelines for evaluation and management of cerebral collateral circulation in ischaemic stroke 2017. Stroke and Vascular Neurology. 2018,3:117-130.
69. Liu H#, Zheng H#, Cao Y, Pan Y, Wang D, Zhang R, You S, Zhang X, Li S, Tong X, Liu CF* and Wang Y*.Low- versus Standard-Dose Intravenous Tissue-Type Plasminogen Activator for Acute Ischemic Stroke: An Updated Meta-Analysis. J Stroke Cerebrovasc Dis. 2018,27(4):988-997.SCI
70. Wangqin R#, Wang X#, Wang Y, Xian Y, Zhao X, Liu L, Li H, Meng X* and Wang Y*.Risk factors associated with 90-day recurrent stroke in patients on dual antiplatelet therapy for minor stroke or high-risk TIA: a subgroup analysis of the CHANCE trial. Stroke and Vascular Neurology. 2017,2(4):176-183.
71. Pan Y., Chen W., Xu Y., Yi X., Han Y., Yang Q., Li X., Huang L., Johnston S. C., Zhao X., Liu L., Zhang Q., Wang G., Wang Y., Wang Y*..Genetic polymorphisms and clopidogrel efficacy for acute ischemic stroke or transient ischemic attack: A systematic review and meta-analysis. Circulation. 2017,135(1):21-33.SCI
72. Jing J., Pan Y., Zhao X., Zheng H., Jia Q., Mi D., Chen W., Li H., Liu L., Wang C., He Y., Wang D., Wang Y., Wang Y*..Insulin resistance and prognosis of nondiabetic patients with ischemic stroke: The across-china study (abnormal glucose regulation in patients with acute stroke across china). Stroke. 2017,48(4):887-893.SCI
73. Wang W., Jiang B., Sun H., Ru X., Sun D., Wang L., Wang L., Jiang Y., Li Y., Wang Y., Chen Z., Wu S., Zhang Y., Wang D., Wang Y., Feigin V. L*..Prevalence, incidence, and mortality of stroke in china: Results from a nationwide population-based survey of 480 687 adults. Circulation. 2017,135(8):759-771.SCI
74. Lin Y., Wang A., Li J., Lin J., Wang D., Meng X., Ou L., Chen W., Zhao X., Liu L., Wang Y., Wang Y*. .Impact of glycemic control on efficacy of clopidogrel in transient ischemic attack o r minor stroke patients with cyp2c19 genetic variants. Stroke. 2017,48(4):998-1004.SCI
75. Pan Y., Jing J., Chen W., Zheng H., Jia Q., Mi D., Li H., Zhao X., Liu L., Wang C., Gaisano H. Y., He Y., Wang Y., Wang Y*..Post-glucose load measures of insulin resistance and prognosis of nondiabetic patients with ischemic stroke. J Am Heart Assoc. 2017,6(1):pii: e004990.SCI
76. Wang Y., Minematsu K., Wong K. S., Amarenco P., Albers G. W., Denison H., Easton J. D., Evans S. R., Held P., Jonasson J., Molina C. A., Johnston S. C*..Ticagrelor in acute stroke o r transient ischemic attack in asian patients: From the socrates trial (acute stroke o r transient ischemic attack treated with aspirin o r ticagrelor a n d patient outcomes. stroke. 2017,48(1):167-173.SCI
77. Li H, Zhang R, Liu G, Liu L, Wang Y and Wang Y*.External Validation of Pooled Cohort Risk Equations to Predict 1-Year Clinical Outcome in Ischemic Stroke Patients. Medical science monitor : international medical journal of experimental and clinical research. Med Sci Monit. 2017,23:4415-4421.SCI
78. Li Z, Singhal AB and Wang Y*.Stroke Physician Training in China. Stroke. 2017,48(12):e338-e340.SCI
79. Lin Y#, Wang A#, Li J, Lin J, Wang D, Meng X, Ou L, Chen W, Zhao X, Liu L, Wang Y, Wang Y* and Investigators C.Impact of Glycemic Control on Efficacy of Clopidogrel in Transient Ischemic Attack or Minor Stroke Patients With CYP2C19 Genetic Variants. Stroke. 2017,48(4):998-1004.SCI
80. Liu M, Pan Y, Zhou L and Wang Y*.Predictors of post-thrombolysis symptomatic intracranial hemorrhage in Chinese patients with acute ischemic stroke. PloS one. 2017,12(9):e**.SCI
81. Liu X, Dornbos D, 3rd, Pu Y, Leng X, Song L, Jia B, Pan Y, Wang D, Miao Z, Wang Y, Liu L and Wang Y*. Collateral circulation alters downstream hemodynamic stress caused by intracranial atherosclerotic stenosis. Neurological research. 2017,39(6):498-503.SCI
82. Pan Y, Jing J, Chen W, Meng X, Li H, Zhao X, Liu L, Wang D, Johnston SC, Wang Y, Wang Y* and investigators C.Risks and benefits of clopidogrel-aspirin in minor stroke or TIA: Time course analysis of CHANCE.. Neurology. 2017,88(20):1906-1911.SCI
83. Song T, Pan Y, Chen R, Li H, Zhao X, Liu L, Wang C, Wang Y and Wang Y*. Is there a correlation between socioeconomic disparity and functional outcome after acute ischemic stroke?. PloS one. 2017,12(7):e**.SCI
84. Liu R, Yang X, Li S, Jiang Y, Wang Y and Wang Y*.Novel composite scoring system to predict unknown atrial fibrillation in acute ischemic stroke patients. Brain Res. 2017,1674:36-41.SCI
85. Pan Y, Meng X, Jing J, Li H, Zhao X, Liu L, Wang D, Johnston SC, Wang Y, Wang Y* and Investigators C. Association of multiple infarctions and ICAS with outcomes of minor stroke and TIA. Neurology. 2017,88(11):1081-1088.SCI
86. Wang A, Liu X, Chen G, Hao H, Wang Y* and Wang Y*.Association between Carotid Plaque and Cognitive Impairment in Chinese Stroke Population: The SOS-Stroke Study. Scientific reports. 2017,7(1):3066.SCI
87. Wang H#, Pan Y#, Meng X, Wang C, Liao X, Wang D, Zhao X, Liu L, Li H, Wang Y* and Wang Y*.Validation of the mSOAR and SOAR scores to predict early mortality in Chinese acute stroke patients. PLoS One. 2017,12(7):e**.SCI
88. Wang H#, Pan Y#, Zhang Z, Li X, Xu Z, Suo Y, Li W* and Wang Y*.A Novel KRIT1/CCM1 Gene Insertion Mutation Associated with Cerebral Cavernous Malformations in a Chinese Family. J Mol Neurosci. 2017,61(2):221-226.SCI
89. Zhang C, Wang Y, Zhao X, Liu L, Wang C, Pu Y, Zou X, Pan Y, Wong KS, Wang Y* and Chinese IntraCranial AtheroSclerosis Study G.Prediction of Recurrent Stroke or Transient Ischemic Attack After Noncardiogenic Posterior Circulation Ischemic Stroke. Stroke. 2017,48(7):1835-1841.SCI
90. Tan Y, Pan Y, Liu L, Wang Y, Zhao X and Wang Y*.One-year outcomes and secondary prevention in patients after acute minor stroke: results from the China National Stroke Registry. Neurological research. 2017,39(6):484-491.SCI
91. Wang Y, Li Z, Zhao X, Wang D, Li H, Xian Y, Liu L and Wang Y*. Stroke care quality in China: Substantial improvement, and a huge challenge and opportunity. Int J Stroke. 2017,12(3):229-235.SCI
92. Wang Y#*, Minematsu K#, Wong KS#, Amarenco P, Albers GW, Denison H, Easton JD, Evans SR, Held P, Jonasson J, Molina CA, Johnston SC*, Committee SS and Investigators. .Ticagrelor in Acute Stroke or Transient Ischemic Attack in Asian Patients: From the SOCRATES Trial (Acute Stroke or Transient Ischemic Attack Treated With Aspirin or Ticagrelor and Patient Outcomes). Stroke. 2017,48(1):167-173.SCI
93. Xie X, Xu J, Gu H, Tao Y, Chen P, Wang Y and Wang Y*.The J-curve Association between Systolic Blood Pressure and Clinical Outcomes in Ischemic Stroke or TIA: The BOSS Study. Scientific reports. 2017,7(1):14023.SCI
94. Wang Y, Lin Y, Meng X, Chen W, Chen G, Wang Z, Wu J, Wang D, Li J, Cao Y, Xu Y, Zhang G, Li X, Pan Y, Li H, Liu L, Zhao X, Wang Y* and Group PPS..Effect of ticagrelor with clopidogrel on high on-treatment platelet reactivity in acute stroke or transient ischemic attack (PRINCE) trial: Rationale and design. Int J Stroke. 2017,12(3):321-325.SCI
95. hang R, Ji R, Pan Y, Jiang Y, Liu G, Wang Y and Wang Y*.External Validation of the Prestroke Independence, Sex, Age, National Institutes of Health Stroke Scale Score for Predicting Pneumonia After Stroke Using Data From the China National Stroke Registry. J Stroke Cerebrovasc Dis. 2017,26(5):938-943.SCI
96. Wang Y*, Liu M and Pu C.2014 Chinese guidelines for secondary prevention of ischemic stroke and transient ischemic attack. Int J Stroke. 2017,12:302-320.SCI
97. Zhang W, Liu X, Zuo L, Guo Q, Chen Q and Wang Y*.Ipsiversive ictal eye deviation in inferioposterior temporal lobe epilepsy-Two SEEG cases report. BMC Neurol. 2017,17(1):38.SCI
98. Xu J, Tao Y, Li H, Gu H, Xie X, Meng X, Xu Y, Wang Y and Wang Y*.Different levels of blood pressure, different benefit from dual antiplatelet therapy in minor stroke or TIA patients. Scientific reports. 2017,7(1):3884.SCI
99. Yang X, Li S, Zhao X, Liu L, Jiang Y, Li Z, Wang Y and Wang Y*.Atrial fibrillation is not uncommon among patients with ischemic stroke and transient ischemic stroke in China. BMC Neurol. 2017,17(1):207.SCI
100. Li Z., Wang Y., Zhao X., Liu L., Wang D., Wang C., Meng X., Li H., Pan Y., Wang X., Wang C., Yang X., Zhang C., Jing J., Xian Y., Johnston S. C., Wang Y*..Treatment effect of clopidogrel plus aspirin within 12 hours of acute minor stroke o r transient ischemic attack. J Am Heart Assoc. 2016,5(3):e003038.SCI
101. Wang Y., Zhao X., Lin J., Li H., Johnston S. C., Lin Y., Pan Y., Liu L., Wang D., Wang C., Meng X., Xu J., Wang Y*..Association between cyp2c19 loss-of-function allele status and efficacy of clopidogrel for risk reduction among patients with minor stroke o r transient ischemic attack. JAMA. 2016,316(1):70-8.SCI
102. Sun S., Pan Y., Zhao X., Liu L., Li H., He Y., Guo L., Wang Y., Wang Y*..The association between impaired glucose regulation and prognosis of chinese patients with intracerebral hemorrhage. Sci Rep. 2016,6:36220.SCI
103. Tong X., Wang C., Liao X., Pan Y., Yan H., Cao Y., Liu L., Zheng H., Zhao X., Wang C., Li H., Wang D., Wang Y., Wang Y*..Thrombolysis Implementation, Monitor of Acute Ischemic Stroke in China Investigators. Smoking-thrombolysis relationship depends on ischemic stroke subtype. Stroke. 2016,47(7):1811-6.SCI
104. Sun S., Pan Y., Zhao X., Liu L., Li H., He Y., Wang Y., Wang Y., Guo L*..Prognostic value of admission blood glucose in diabetic and non-diabetic patients with intracerebral hemorrhage. Sci Rep. 2016,6:32342.SCI
105. Yang X., Wang A., Liu X., An S., Chen S., Wang Y*..Wu S. Positive changes in ideal cvh metrics reduce the incidence of stroke. Sci Rep. 2016,6:19673.SCI
106. Li Z., Wang C., Zhao X., Liu L., Wang C., Li H., Shen H., Liang L., Bettger J., Yang Q., Wang D., Wang A., Pan Y., Jiang Y., Yang X., Zhang C., Fonarow G. C., Schwamm L. H., Hu B., Peterson E. D., Xian Y., Wang Y., Wang Y*..Substantial progress yet significant opportunity for improvement in stroke care in china. Stroke. 2016,47(11):2843-2849.SCI
107. Pan Y., Chen R., Li Z., Li H., Zhao X., Liu L., Wang C., Wang Y., Wang Y*..Socioeconomic status and the quality of acute stroke care: The china national stroke registry. Stroke. 2016,47(11):2836-2842.SCI
108. Li J., Wang Y., Lin J., Wang D., Wang A., Zhao X., Liu L., Wang C., Wang Y*..Soluble cd40l is a useful marker to predict future strokes in patients with minor stroke and transient ischemic attack . Stroke. 2015,46(7):1990-2..SCI
109. Chen W., Pan Y., Zhao X., Liao X., Liu L., Wang C., Wang Y., Wang Y*..Totaled health risks in vascular events score predicts clinical outcome and symptomatic intracranial hemorrhage in chinese patients after thrombolysis . Stroke. 2015, 46(3): 864-6.SCI
110. Li J., Wang Y., Wang D., Lin J., Wang A., Zhao X., Liu L., Wang C., Wang Y*..Glycated albumin predicts the effect of dual and single antiplatelet therapy on recurrent stroke. Neurology. 2015,84(13):1330-6.SCI
111. Wang Y., Pan Y., Zhao X., Li H., Wang D., Johnston S. C., Liu L., Meng X., Wang A., Wang C., Wang Y*..Clopidogrel with aspirin in acute minor stroke o r transient ischemic attack (chance) trial: One-year outcomes. Circulation. 2015,132(1):40-6.SCI
112. Lin J., Zheng H., Cucchiara B. L., Li J., Zhao X., Liang X., Wang C., Li H., Mullen M. T., Johnston S. C., Wang Y., Wang Y*..Association of lp-pla2-a and early recurrence of vascular events after tia and minor stroke. Neurology. 2015,85(18):1585-91.SCI
113. Liu L., Wong K. S., Leng X., Pu Y., Wang Y., Jing J., Zou X., Pan Y., Wang A., Meng X., Wang C., Zhao X., Soo Y., Johnston S. C., Wang Y*..Dual antiplatelet therapy in stroke and icas: Subgroup analysis of chance . Neurology. 2015,85(13):1154-62.SCI
114. Wang Y., Zhao X., Jiang Y., Li H., Wang L., Johnston S. C., Liu L., Wong K. S., Wang C., Pan Y., Jing J., Xu J., Meng X., Zhang M., Li Y., Zhou Y., Zhao W., Wang Y*..Prevalence, knowledge, and treatment of transient ischemic attacks in china. Neurology. 2015,84(23):2354-61.SCI
115. Wang Y., Zhao X., Liu L., Soo Y. O., Pu Y., Pan Y., Wang Y., Zou X., Leung T. W., Cai Y., Bai Q., Wu Y., Wang C., Pan X., Luo B., Wong K. S., Group Cicas Study, Additional members of the Cicas study group are as follows..Prevalence and outcomes of symptomatic intracranial large artery stenoses and occlusions in china: The chinese intracranial atherosclerosis (cicas) study.. Stroke. 2014, 45(3): 663-669.SCI
116. 30.Wang X, Luo Y, Wang Y, Wang C, Zhao X, Wang D, Liu L, Liu G, Wang Y*, China National Stroke Registry I. . Comparison of associations of outcomes after stroke with estimated GFR using Chinese modifications of the MDRD study and CKD-EPI creatinine equations: results from the China National Stroke Registry.. American journal of kidney disease. 2014,63:59-67.SCI
117. 6.Ji R, Shen H, Pan Y, Du W, Wang P, Liu G, Wang Y, Li H, Zhao X, Wang Y*, China National Stroke Registry i..Risk score to predict hospital-acquired pneumonia after spontaneous intracerebral hemorrhage. Stroke. 2014,45:2620-2628..SCI
118. Pu Y., Liu L., Wang Y., Zou X., Pan Y., Soo Y., Leung T., Zhao X., Wong K. S., Wang Y., Chinese IntraCranial AtheroSclerosis Study Group..Geographic and sex difference in the distribution of intracranial atherosclerosis in china.. stroke. 2013,44(8):2109-2114.SCI
119. Wong K. S. L., Wang Y., Leng X., Mao C., Tang J., Bath P. M. W., Markus H. S., Gorelick P. B., Liu L., Lin W., Wang Y..Early dual versus mono antiplatelet therapy for acute non-cardioembolic ischemic stroke or transient ischemic attack: An updated systematic review and meta-analysis.. Circulation. 2013, 128(15):1656-1666.SCI
120. Zhang N., Liu G., Zhang G., Fang J., Wang Y., Zhao X., Pan Y., Guo L., Wang Y., On behalf of the China National Stroke Registry Investigators..External validation of the iscore for predicting ischemic stroke mortality in patients in china. stroke. 2013,44(7):1924-1929.SCI
121. Ji R., Wang D., Shen H., Pan Y., Liu G., Wang P., Wang Y., Li H., Wang Y., China National Stroke Registry Investigators..Interrelationship among common medical complications after acute stroke: Pneumonia plays an important role.. Stroke. 2013,44(12):3436-3444.SCI
122. Wang Y., Wang Y., Zhao X., Liu L., Wang D., Wang C., Wang C., Li H., Meng X., Cui L., Jia J., Dong Q., Xu A., Zeng J., Li Y., Wang Z., Xia H., Johnston S. C., the Chance Investigators..Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med. 2013, 369(1):11-19.SCI
123. Wang Y, Xu J, Zhao X, Wang D, Wang C, Liu L, Wang A, Meng X, Li H, Wang Y..Association of hypertension with stroke recurrence depends on ischemic stroke subtype.. Stroke. 2013,44(5):1232-7.SCI
124. Liu G, Ntaios G, Zheng H, Wang Y, Michel P, Wang DZ, Fang J, Papavasileiou V, Liu L, Dong K, Wang C, Zhao X, Wang Y..External Validation of the ASTRAL Score to Predict 3- and 12-Month Functional Outcome in the China National Stroke Registry.. stroke. 2013,44(5):1443-5.SCI
125. Ji R, Shen H, Pan Y, Wang P, Liu G, Wang Y, Li H, Wang Y; China National Stroke Registry Investigators.Novel risk score to predict pneumonia after acute ischemic stroke.. stroke. 2013,44(5):1303-9.SCI
126. Zhang N., Liu G., Zhang G., Fang J., Wang Y., Zhao X., Guo L., Wang Y..A risk score based on get with the guidelines-stroke program data works in patients with acute ischemic stroke in china. Stroke. 2012,43(11) :3108-3109.SCI
127. Jia Q., Zheng H., Zhao X., Wang C., Liu G., Wang Y., Liu L., Li H., Zhong L..Abnormal glucose regulation in patients with acute stroke across china: Prevalence and baseline patient characteristics. stroke. 2012,43(3):650-657.SCI
128. Wang Y, Cui L, Ji X, Dong Q, Zeng J, Wang Y, Zhou Y, Zhao X, Wang C, Liu L, Nguyen-Huynh MN, Claiborne Johnston S, Wong L, Li H; China National Stroke Registry Investigators..The China National Stroke Registry for patients with acute cerebrovascular events: design, rationale, and baseline patient characteristics. International Journal of Stroke. 2011,6(4):355-61.SCI
129. Meng X, Wang Y, Liu L, Pu Y, Zhao X, Wang C, Wang Y*..Validation of the abcd(2)-i score to predict stroke risk after transient ischemic attack.. Neurological Research. 2011,33(5):482-6.SCI
130. Liu L, Wang D, Wong KS, Wang Y*..Stroke and stroke care in china: huge burden, significant workload, and a national priority. stroke. 2011,42(12):3651-4.SCI
131. Gao S;Wang YJ;Xu AD;Li YS;Wang DZ.Chinese ischemic stroke subclassification. Frontiers in Neurology. 2011,6:1.SCI
132. Fang R, Zhang N, Wang C, Zhao X, Liu L, Wang Y, Xu J, Wang X, Liu Z, Wang Y*..Relations between plasma Ox-LDL and carotid plaque among Chinese Han ethnic group. Neurological Research. 2011,33(5):460-6.SCI
133. Jia Q, Zhao X, Wang C, Wang Y, Yan Y, Li H, Zhong L, Liu L, Zheng H, Zhou Y, Wang Y*..Diabetes and poor outcomes within 6 months after acute ischemic stroke: the China National Stroke Registry. Stroke. 2011,42(10):2758-62.SCI
134. Meng X, Wang Y, Zhao X, Wang C, Li H, Liu L, Zhou Y, Xu J, Wang Y*..Validation of the Essen Stroke Risk Score and the Stroke Prognosis Instrument II in Chinese Patients. stroke. 2011,42(12):3619-20.SCI
135. Wang Y, Liao X, Zhao X, Wang DZ, Wang C, Nguyen-Huynh MN, Zhou Y, Liu L, Wang X, Liu G, Li H, Wang Y*; China National Stroke Registry Investigators..Using Recombinant Tissue Plasminogen Activator to Treat Acute Ischemic Stroke in China: Analysis of the Results From the Chinese National Stroke Registry (CNSR). Stroke. 2011,42(6):1658-64.SCI
136. Zhao R, Wang Y, Shen R, Sun Y.Relationship between CX3CR1 genetic polymorphism and carotid atherosclerosis. Artif Cells Blood Substit Immobil Biotechnol. 2010,38(1):19-23.SCI
137. Zhang Y, Wang C, Zhao X, Chen H, Han Z, Wang Y*.Diffusion tensor imaging depicting damage to the arcuate fasciculus in patients with conduction aphasia: a study of the Wernicke-Geschwind model. Neurological Research. 2010,32(7):775-8.SCI
138. Jia Q, Liu LP, Wang YJ*.Stroke in China. Clinical and Experimental Pharmacology and physiology. 2010,37(2):259-64.SCI
139. Zhang T, Wang C, Liu L, Zhao X, Xue J, Zhou Y, Wang Y*.A prospective cohort study of the incidence and determinants of post-stroke depression among the mainland chinese patients. Neurological Research. 2010,32(4):347-52.SCI
140. Wang Y*, Johnston SC.Rationale and design of a randomized, double-blind trial comparing the effects of a 3-month clopidogrel-aspirin regimen versus aspirin alone for the treatment of high-risk patients with acute nondisabling cerebrovascular event. Am Heart J. 2010,160(3):380-386.SCI
141. Zhao QL, Zhou Y, Wang YL, Dong KH, Wang YJ*.A new diagnostic algorithm for vascular cognitive impairment: the proposed criteria and evaluation of its reliability and validity. Chin Med J. 2010,123(3):311-9.SCI
142. Jia Q, Zheng H, Liu L, Zhao X, Wang C, Jing J, Liang D, Wang Y*, Zhou Y, Dong K, Yang Z.Persistence and predictors of abnormal glucose metabolisms in patients after acute stroke. Neurological Research. 2010,32(4):359-65.SCI
143. Wang YL, Wu D, Nguyen-Huynh MN, Zhou Y, Wang CX, Zhao XQ, Liao XL, Liu LP, Wang YJ*.Antithrombotic management of ischaemic stroke and transient ischaemic attack in China: a consecutive cross-sectional survey. Clinical and Experimental Pharmacology and physiology. 2010,37(8):775-81.SCI
144. Zhang Z Q，Niu S T，Liang X H，Jian F，Wang Y J*.Vascular involvement in the pathogenesis of mitochondrial encephalomyopathies. Neurological Research. 2010,32(4):403-8.SCI
145. Wang Y, Liao X, Zhao X, Wang C, Liu L, Zhou Y, Wang C, Xue J, Gao P, Dong K, Ji X, Wang Y*; ITAIS-II investigators.Imaging-based thrombolysis trial in acute ischemic stroke-II (ITAIS-II). Int J Stroke. 2009,4(1):49-53.SCI
146. Feng T, Li W, Lu L, Wang Y, Shi W, Zhang J, Wang Y, Chan P..Acute stepwise challenge test with levodopa in treated patients with parkinsonism. Parkinsonism Relat Disord. 2009,15(5):354-8.SCI
147. Pu Y, Liu L, Zou X, Chen P, Wang Y, Zhou Y, Dong K, Zhao X, Wang C, Wang Y*.Relationship between leukoaraiosis and cerebral large artery stenosis. Neurol Res.. 2009,31(4):376-380.SCI
148. 周永,王伊龙,吴敌,赵性泉,王拥军*.卒中患者院前转运与延误现况调查——一项来自中国七城市卒中事件急诊登记数据库研究(CARDs). 中国全科医学. 2009,12(2):96-99.核心期刊
149. Wang Y, Wu D, Zhao X, Ma R, Guo X, Wang C, Liu L, Zhao W, Wang Y..Hospital resources for urokinase/recombinant tissue-type plasminogen activator therapy for acute stroke in Beijing. Surg Neurol. 2009,72（S2）:S1-7.SCI
150. 王春雪,王拥军*.他汀类药物治疗缺血性脑血管病新理论与实践. 中国实用内科杂志. 2009,29(1):12-14.核心期刊
151. 王伊龙,吴敌,周永,赵性泉,王春雪,王拥军* .中国七城市卒中患者急诊溶栓情况分析. 中国卒中杂志. 2009,4(1):23-28.核心期刊
152. Wang Y, Liao X, Zhao X, Wang C, Liu L, Zhou Y, Wang C, Xue J, Gao P, Dong K, Ji X, Wang Y*; ITAIS-II investigators. .Imaging-based thrombolysis trial in acute ischemic stroke-II (ITAIS-II).. Int J Stroke. . 2009,4(1):49-53.SCI
153. Gao T, Zhang Z, Yu W, Zhang Z, Wang Y*.Atherosclerotic carotid vulnerable plaque and subsequent stroke: a high-resolution MRI study.. Cerebrovasc Dis.. 2009,27(4):345-52.SCI
154. Wang C, Li J, Zhao X, Wang Y, Wu D, Wang Y..Stroke care development in Mainland China: past, present and future. Int J Stroke. . 2008,3(4):288-9.SCI
155. Ma R, Wang C, Zhao X, Xu M, Lv Y, Wei M, Cai Y, Zhang Z, Wang L, Zhang W, Huang Y, Li Y, Li H, Wang Y..A survey on compliance with secondary stroke prevention guidelines and follow up for the inpatients with atherosclerotic cerebral infarction/transient ischemic attack.. Neurol Res. . 2008,30(4):383-8.SCI
156. Xue L, Yu Q, Zhang H, Liu Y, Wang C, Wang Y..Effect of large dose hyperbaric oxygenation therapy on prognosis and oxidative stress of acute permanent cerebral ischemic stroke in rats. Neurol Res. . 2008,30(4):389-93.SCI
157. 赵性泉,廖晓凌,王伊龙,王亚捷,汪璇,王拥军.急性脑梗死患者超早期血清基质金属蛋白酶水平与磁共振改变的相关性. 临床神经病学杂志. 2008,21(2):85-87.核心期刊
158. Gao T*, Wang Y, Zhang Z.Silent cerebral microbleeds on susceptibility-weighted imaging of patients with ischemic stroke and leukoaraiosis. Neurological Research. 2008,30(3):272-6.SCI
159. Wang Y, Wu D, Zhao X, Ma R, Guo X, Wang C, Liu L, Zhao W, Wang Y..Survey of blood pressure control status in patients with ischemic stroke or transient ischemic attack in China.. Neurol Res.. 2008,30(4):348-55.SCI
160. Qin H, Sui B, Zhang W, Zhao X, Wang G, Zhou Y, Gao P, Wang Y..Is high-resolution magnetic resonance imaging or ultrasonography better for prediction of clinical events induced by carotid vulnerable lesions?. Neurol Res. . 2008,30(4):361-5.SCI
161. Zheng H, Liu L, Sun H, Wang X, Wang Y, Zhou Y, Lu J, Zhao X, Wang C, Dong K, Yang Z, Wang Y..Prophylaxis of deep venous thrombosis and adherence to guideline recommendations among inpatients with acute stroke: results from a multicenter observational longitudinal study in China.. Neurol Res. . 2008,30(4):370-6.SCI
162. Zheng H, Liu L, Sun H, Wang X, Wang Y, Zhou Y, Lu J, Zhao X, Wang C, Dong K, Yang Z, Wang Y..Prophylaxis of deep venous thrombosis and adherence to guideline recommendations among inpatients with acute stroke: results from a multicenter observational longitudinal study in China.. Neurol Res. . 2008,30(4):370-6.SCI
163. 高晗清,王拥军*.缺血性卒中预防的分层策略 . 《内科急危重症杂志》. 2008,14(3):117-120.核心期刊
164. 王拥军,刘力生,饶克勤,徐希平 .我国脑卒中预防策略思考:同时控制高血压和高同型半胱氨酸水平. 中华医学杂志. 2008,88(47):3316-3318.核心期刊
165. 王春雪, 王拥军*.他汀类药物预防缺血性卒中/TIA的安全性. 中国卒中杂志. 2007,2(4):332-334.核心期刊
166. 廖晓凌, 王伊龙, 王拥军*, 薛静, 高培毅 .急性缺血性卒中超早期不同梗死部位分型的临床特征及预后. 中国康复理论与实践. 2007,13（3）:212-214.核心期刊
167. 濮月华, 王拥军*, 赵性泉, 柴锡庆, 艾青 .自发性脑出血30天病死率的预测方法研究. 中国卒中杂志. 2007,2（6）:475-481.核心期刊
168. 廖晓凌, 王伊龙, 王拥军*, 薛静, 高培毅.急性颈内或大脑中动脉闭塞患者临床预后分析. 中国康复理论与实践. 2007,13（8）:714-715.核心期刊
169. Yongqing Zhao, Chengyun Ding, Yongjun Wang, Zhimei Li, Yong Zhou, Yuming Huang.Reliability and validity of a Chinese version of the Quality of Life in Epilepsy Inventory (QOLIE-89) . Epilepsy & Behavior. 2007,11(1):53-59 .SCI
170. Wang YJ*.A survey on adherence to secondary ischemic. Neurological Research. 2006,28（1）:16-21.SCI
171. Gong XP, Li Y, Jiang WJ, Wang YJ, et al.Impaired dynamic cerebral autoregulation in middle cerebral artery stenosis. Neurological Research. 2006,28（1）:76-81.SCI
172. Jiang WJ, Gao F, Du B, Srivastava T, Wang YJ.Limb-shaking transient ischemic attack induced by middle cerebral artery stenosis. Neurological Research. 2006,21(5-6):421－422.SCI
173. 王拥军.钙通道阻滞剂防治脑血管病专家共识. 中华内科杂志. 2006,45(3):261-262.EI
174. 王拥军.低分子量肝素在脑血管疾病中应用的专家共识. 中华内科杂志. 2005,44(11):874-875.EI
175. 王拥军.脑血管疾病与认知功能障碍. 中华内科杂志. 2005,44(11):872-873.EI
176. 王拥军.建立中国癫痫临床诊疗指南的意义. 北京医学. 2005,27(11):678-680.EI
177. 王拥军.卒中——回眸2004. 内科急危重症杂志. 2005,11(5):199-202.EI
178. 王拥军.建立卒中单元,完成卒中医疗模式的转变 . 中国康复医学杂志. 2005,20（4）:243-243.EI
179. 王拥军.重症病人需要多模式神经功能监测. 中华内科杂志. 2005,44（4）:242-243.EI
180. 王拥军.短暂性脑缺血发作的新概念. 国外医学.脑血管疾病分册. 2005,13（2）:81-88.核心期刊
181. 王拥军.高血压与脑卒中. 中华心血管病杂志. 2004,32（6）:574-576.EI
182. 王拥军*.银杏达莫注射液治疗急性脑梗死的临床研究. 中华老年医学杂志. 2004,23（1):48-49.EI
183. 王拥军*.脑死亡:不得不面对的医学问题. 中华内科杂志. 2004,43（4）:241-242.EI
184. 王拥军*.卒中单元的模式及建立. 中国医刊. 2004,39（1）:12-13.核心期刊
185. 王拥军.卒中单元与普通病房的早期疗效比较. 中国临床康复. 2004,8（19）:3716-3717.EI
186. Jiang WJ,Wang YJ, et al.Stenting of sumptomatic M1 stenosis of middle cerebral artery. Stroke. 2004,35:1375-1380.SCI
187. Ma RH, Wang YJ, et al.Assessment of early effectiveness of a stroke unit in comparison to the general ward. Chinese Medical Journal. 2004,35:1375-1380.SCI
188. 王拥军.脑卒中防治中的降压治疗. 中华内科杂志. 2004,43（10）:726-727.EI
189. 王拥军.氯吡格雷(波立维)预防与治疗缺血性脑血管病. 中国处方药. 2004,5:43-44.核心期刊
190. 王拥军*.九年积累,九年磨砺——评2003版AHA缺血性卒中的早期处理指南. 国外医学.脑血管疾病分册. 2003,11(5):321-322.核心期刊
191. 王拥军.颅内血管狭窄的诊断与治疗 . 中华内科杂志. 2003,42(8):531-532.EI
192. 王拥军*.卒中单元:脑血管病医疗的方向 . 中华全科医师杂志. 2003,2(4):215-217.EI
193. 王拥军*.循证医学——是工具还是圣经?. 国外医学.脑血管疾病分册. 2003,11(1):38-40.核心期刊
194. 王拥军*.缩小脑血管病预防中循证医学与实践的距离. 中华预防医学杂志. 2003,37(2):79-80.EI
195. 王拥军*.脑梗死急性期血压控制规范. 心脑血管病防治. 2003,3(6):3-4.核心期刊
196. 王拥军*.组织化卒中医疗的概念及国内外特征. 中国临床康复. 2003,7(1):6-7.EI
主编或副主编的著作/译著
1. 《中国脑血管病临床管理指南》,主编,人民卫生出版社,2019
2. 《脑卒中诊疗王拥军2019观点》,主编,科学技术文献出版社,2019
3. 《泛血管医学-概念及常见疾病诊治》,主编,人民卫生出版社,201808
4. 《临床路径释义-神经内科分册》,主编,中国协和医科大学出版社,201807
5. 《红手环 感动中国 第二辑》,主编,科学技术文献出版社,201806
6. 《遗传性脑血管病诊断手册II》,主编,科学出版社,201806
7. 《脑海深处 2》,主编,科学技术文献出版社,201801
8. 《血管神经病学精要》,主译,人民卫生出版社,2018
9. 《2017神经内科医疗质量报告》,主编,人民卫生出版社,2018
10. 《神经病学新进展》,主编,人民卫生出版社,2018
11. 《遗传性脑血管病诊断手册》,主编,科学出版社,2017
12. 《中国脑血管病临床研究年鉴2015》,主编,科学出版社,2017
13. 《脑卒中诊疗王拥军2017观点》,主编,科学技术文献出版社,2017
14. 《脑健康读本》,主编,科学技术文献出版社,2017
15. 《精准医疗与药物治疗个体化实操手册》,主编,科学技术文献出版社,2017
16. 《神经系统单基因病诊断学（上中下卷）》,主编,科学出版社,2017
17. 《2016神经内科医疗质量报告》,主编,人民卫生出版社,2017
18. 《Caplan卒中临床实践第5版》,主译,人民卫生出版社,2017
19. 《卒中中心手册》,主编,人民卫生出版社,201606
20. 《神经内科学高级教程》,主编,中华医学电子音像出版社,2016
21. 《中国慢性疾病防治基层医生诊疗手册神经病学分册（上）-卒中2016年版》,主编,北京大学医学出版社,2016
22. 《基层脑血管病规范诊疗手册》,主编,中国协和医科大学出版社,2016
23. 《神经内科常见病临床思路精解》,主编,科学技术文献出版社,2016
24. 《血管神经病学》,主编,科学出版社,201502
25. 《脑海深处》,主编,科学技术文献出版社,2015
26. 《神经内科学高级教程2012》,主编,人民军医出版社,201204
27. 《缺血性卒中与短暂性脑缺血发作二级预防——从指南到实践》,主编,北京大学医学,201201
28. 《脑卒中神经影像学实例解析》,主译,北京大学医学出版社,201106
29. 《图解神经病学与神经外科学（第5版）》,主译,北京大学医学出版社,201106
30. 《Caplan脑卒中——临床实践（第4版）》,主译,北京大学医学出版社,201006
31. 《神经病学（第2版）》,主编,北京大学医学出版社,200909
32. 《神经病学（神经内科专科医师培训用书）》,主编,科学出版社,2009
33. 《神经内科专科医师考核辅导《神经病学》配套用书》,主编,北京大学医学出版社,2009
34. 《脑血管病临床手册系列》,主编,人民卫生出版社,200809
35. 《神经病学》,主编,科技文献出版社,200601
36. 《神经内科医师效率手册》,主编,中国协和医科大学出版社,2005
37. 《神经病学临床评定量表》,主编,中国友谊出版公司,2005
38. 《卒中单元》,主编,科学技术文献出版社,2004
39. 《神经病学》,主编,科学技术文献出版社,2003
40. 《BNC脑血管病临床指南》,主编,人民卫生出版社,2003
41. 《现代神经病学进展（2）》,主编,科学技术文献出版社,2001
42. 《现代神经病学进展（1）》,主编,科学技术文献出版社,1999
43. 《神经病学实验室诊断技术》,主编,科学技术文献出版社,1998
44. 《脑血管病：你能战胜它》,主编,科学技术文献出版社,1998
重要奖项
1. 2018精诚医者 2018精诚医者 201901
2. 十大领导力院管专家 十大领导力院管专家 201901
3. 北京市医院管理中心 优秀共产党员 北京市医院管理中心 优秀共产党员 2019
4. 吴阶平医学基金会推选 吴阶平医药创新奖 一 201809
5. 全国住院医师规范化培训“优秀专业基地主任” 全国住院医师规范化培训“优秀专业基地主任” 201809
6. 高危非致残性脑血管病及其防控关键技术与应用 国家科学技术进步奖 二等奖 201612
7. 缺血性脑血管病复发风险评估与防治优化新策略 教育部科技进步奖 一等奖 201412
8. 缺血性脑血管病医疗质量评价与防治优化体系的建立和临床应用 北京市科学进步奖 一等奖 201412
9. 第八届“药明康德生命化学研究奖” 杰出成就奖 201412
10. 动脉粥样硬化性脑血管病的流行病学与防治研究 中华预防医学会科学技术奖 一 201311
11. 脑卒中急性期四项内科关键诊疗技术研究 首都十大疾病科技公关优秀组织管理团队奖 201210
12. 脑卒中急性期四项内科关键诊疗技术研究 首都十大疾病科技公关惠民型科技成果奖 201210
13. 国家科学技术进步奖 国家科学技术进步奖 2 2007
14. 教育部科技进步一等奖 教育部科技进步一等奖 1 200512
15. 教育部国家科学技术奖 教育部国家科学技术奖 1/3 2003
16. 北京市卫生局科技进步奖 北京市卫生局科技进步奖 1/1 1998
17. 国家体委科技进步奖 国家体委科技进步奖 3/2 1997
18. 北京市科技进步奖 北京市科技进步奖 2/2 199606
19. 北京市科技进步奖 北京市科技进步奖 3/3 199207
20. 北京市卫生局科技进步奖 北京市卫生局科技进步奖 2/1 199101
21. 北京市科技进步奖 北京市科技进步奖 3/4 199001